Epi-Centers for the Prevention of Healthcare-Associated Infections, Antimicrobial Resistance and Adverse Events ¿ Multicenter Expansion of Current Investigation
Funding Opportunity Number: RFA-CK-11-0010401SUPP14 Opportunity Category: ContinuationFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.084Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-CDC-HHSCDCERAClosing Date: Apr 30, 2014Award Ceiling: $1,000,000Expected Number of Awards: 5Creation Date: Mar 14, 2014Funding Opportunity Description: The CDC Prevention Epicenters Program has been established to develop, implement and evaluate the effectiveness of epidemi...
Source: Grants.gov - March 15, 2014 Category: Research Tags: Health Source Type: funding
Partnerships for Diagnostics to Address Antimicrobial Resistance of Select Bacterial Pathogens (R01)
Funding Opportunity Number: RFA-AI-14-019 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthCFDA Number: 93.85593.856Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with...
Source: Grants.gov - March 13, 2014 Category: Research Tags: Health Source Type: funding
Partnerships for Diagnostics to Address Antimicrobial Resistance of Select Bacterial Pathogens (R01)
Funding Opportunity RFA-AI-14-019 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit research applications for projects focused on development and/or production of diagnostics that will enable rapid, sensitive, specific, culture-independent detection of high-priority antimicrobial-resistant Gram-negative bacterial pathogens. This FOA is focused on select healthcare-associated bacteria where resistance compromises effective treatment, including: Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter species and extra-intes...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 11, 2014 Category: Research Source Type: funding
DOD Military Infectious Diseases Applied Research Award
Funding Opportunity Number: W81XWH-14-DMRDP-MID-ARA Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.420Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-AMRAAClosing Date: Sep 30, 2013Award Ceiling: $0Expected Number of Awards: 5Creation Date: Jul 30, 2013Funding Opportunity Description: All applications MUST spe...
Source: Grants.gov - July 31, 2013 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
STD Laboratory-based Surveillance and Gonococcal Isolate Surveillance Project (GISP)
Funding Opportunity Number: CDC-RFA-PS14-1401 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.977Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-CDCClosing Date: Aug 13, 2013Award Ceiling: $500,000Expected Number of Awards: 5Creation Date: May 14, 2013Funding Opportunity Description: The purpose of this FOA is to establish a network of reference laboratories to provide specialized laboratory-based testing and surveillanc...
Source: Grants.gov - May 16, 2013 Category: Research Tags: Health Source Type: funding
Notice of Correction to Award Information in RFA-AI-13-024 Pharmacological Approaches to Evaluating Drug Regimens to Address Antimicrobial Resistance (R01)
Notice NOT-AI-13-042 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 1, 2013 Category: Research Source Type: funding
DOD Military Infectious Diseases Applied Research Award
Funding Opportunity Number: W81XWH-14-DMRDP-MID-ARA Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.420Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-AMRAAClosing Date: Sep 30, 2013Award Ceiling: $0Expected Number of Awards: 5Creation Date: Apr 24, 2013Funding Opportunity Description: All applications MUST spe...
Source: Grants.gov - April 27, 2013 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
Pharmacological Approaches to Evaluating Drug Regimens to Address Antimicrobial Resistance (R01)
Funding Opportunity Number: RFA-AI-13-024 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthCFDA Number: 93.85593.856Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with...
Source: Grants.gov - April 18, 2013 Category: Research Tags: Health Source Type: funding
Pharmacological Approaches to Evaluating Drug Regimens to Address Antimicrobial Resistance (R01)
Funding Opportunity RFA-AI-13-024 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support antimicrobial pharmacokinetic and pharmacodynamic (PK/PD) studies of drug combinations or sequentially administered (sequenced) antimicrobial agents in relevant in vitro and animal models to enhance understanding of the host, drug and microbial factors that contribute to the emergence of antimicrobial drug resistance in clinically relevant pathogens with a goal of minimizing the potential for development of resistance. A secondary objective is to establish partnerships among anti-microbial pharmacologi...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 18, 2013 Category: Research Source Type: funding
